Trial Profile
UW-CTRI Smoking Cessation Medication Tolerability Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Varenicline (Primary) ; Nicotine; Nicotine
- Indications Smoking withdrawal
- Focus Adverse reactions
- 13 Sep 2017 Status changed from active, no longer recruiting to completed.
- 15 Apr 2016 Status changed from recruiting to active, no longer recruiting.
- 01 Apr 2016 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.